Aspen Aerogels (ASPN) Tops Q3 EPS by 11c; Offers FY23 Guidance
Tweet
Share
E-mailGet Alerts ASPN Hot Sheet
Price: $6.41 +1.42%
Revenue Growth %: -46.7%
Financial Fact:
Income (Loss) from Operations: -3.06M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -46.7%
Financial Fact:
Income (Loss) from Operations: -3.06M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Aspen Aerogels (NYSE: ASPN) reported Q3 EPS of ($0.19), $0.11 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $60.8 million versus the consensus estimate of $50.8 million.
GUIDANCE:
Aspen Aerogels sees FY2023 EPS of ($0.90)-($0.76), versus the consensus of ($1.04). Aspen Aerogels sees FY2023 revenue of $225 million, versus the consensus of $216 million.
For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AeroVironment restates quarterly financials, citing $89M goodwill error
- Morgan Stanley Resumes Global Payments (GPN) at Equalweight
- AbbVie agrees to acquire Apogee Therapeutics for $10.9 billion
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
